Abstract
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as
successful growth driver for Big Pharma. The launch and rapid uptake of novel,
high-price products such as Wyeth' s Prevnar or Merck & Co' s Gardasil, along
with the emergence of novel vaccine technologies and favourable legislation
have brought vaccines back into the main focus of pharmaceutical and biotech
companies.
Scope of this research
- Market overview with current market assessment in terms of leading
players, brands and geographies
- In-depth analyses of the leading 5 players' portfolios, R&D pipelines,
sales trends, geographic spread, licensing patterns and strategic outlook
- Discussion of key developments shaping the sector: new technologies,
indications and geographies
- Snapshot profiles of second tier companies in the sector: strength in
specialties
Research and analysis highlights
With the exception of influenza, only two to three vaccine manufacturers
compete for each disease. This lack of competition combined with public health
requirements to guarantee a stable supply of vaccines has resulted in a recent
upward shift of vaccine prices for specialty vaccines.
The most significant threat to the oligopoly of the Big 5 in the vaccines
market comes from companies from emerging markets, which have large
manufacturing capacities for biologics and are able to produce even complex
substances like vaccines at low costs.
While vaccine sales have grown at a CAGR of 32% between 2004 and 2007 and
shown an annual growth rate of 46% between 2006 and 2007, overall
pharmaceutical sales have grown much more slowly, with both the 2004-2007 CAGR
as well as the growth rate between 2006 and 2007 only reaching 8%.
Key reasons to purchase this research
- Get a comprehensive, insightful commercial overview of the vaccines market
- Learn about the strategies of the Big 5 players, their strengths,
weaknesses, similarities and differences
- Gain insight into the future directions and growing strategic importance
of vaccines for Big Pharma
| 
View Cart
